| HORIZON | TRADES | WIN RATE | INSIDER RETURN | SPY RETURN | MEAN EXCESS | MEDIAN EXCESS | T-STAT |
|---|---|---|---|---|---|---|---|
| 7d | 11 | +18.18% | +4.23% | -0.04% | +4.27% | +4.48% | — |
| 14d | 11 | +27.27% | +4.83% | -0.42% | +5.24% | +7.73% | — |
| 30d | 11 | +63.64% | +3.49% | +0.57% | +2.91% | +1.13% | — |
| 60d | 11 | +45.45% | +18.73% | +3.25% | +15.48% | +2.15% | — |
| 90d | 11 | +36.36% | +15.08% | +4.60% | +13.01% | +7.92% | — |
| 180d | 11(2 pending) | +55.56% | +16.56% | +10.14% | +6.42% | -19.18% | — |
| 1y | 11(3 pending) | +12.50% | +52.14% | +24.93% | +27.21% | +5.70% | — |
| 2y | 11(5 pending) | +66.67% | -14.81% | +42.40% | -57.21% | -57.07% | — |
| COMPANY | TYPE | SHARES | PRICE | VALUE | HELD AFTER | TRADE DATE | FILED | DETAILS |
|---|---|---|---|---|---|---|---|---|
| CGEM CULLINAN THERAPEUTICS, INC. | SALE Chief Medical Officer | 4,582 | $14.47 | $66.3K | 159,968 | Feb 24, 2026 | Feb 25, 2026 ↗ | View → |
| CGEM CULLINAN THERAPEUTICS, INC. | SALE Chief Medical Officer | 4,982 | $13.62 | $67.9K | 164,550 | Feb 20, 2026 | Feb 23, 2026 ↗ | View → |
| CGEM CULLINAN THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 300,000 | — | — | 300,000 | Feb 18, 2026 | Feb 19, 2026 ↗ | View → |
| CGEM CULLINAN THERAPEUTICS, INC. | SALE Chief Medical Officer | 4,632 | $9.67 | $44.8K | 169,532 | Dec 18, 2025 | Dec 19, 2025 ↗ | View → |
| CGEM CULLINAN THERAPEUTICS, INC. | SALE Chief Medical Officer | 4,895 | $8.53 | $41.8K | 174,164 | Feb 25, 2025 | Feb 27, 2025 ↗ | View → |
| CGEM CULLINAN THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 130,000 | — | — | 130,000 | Feb 19, 2025 | Feb 21, 2025 ↗ | View → |
| CGEM CULLINAN THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 65,000 | — | — | 179,059 | Feb 19, 2025 | Feb 21, 2025 ↗ | View → |
| CGEM CULLINAN THERAPEUTICS, INC. | SALE Chief Medical Officer | 4,632 | $11.41 | $52.9K | 114,059 | Dec 18, 2024 | Dec 20, 2024 ↗ | View → |
| CGEM CULLINAN THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 62,500 | — | — | 118,691 | Feb 22, 2024 | Feb 23, 2024 ↗ | View → |
| CGEM CULLINAN THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 125,000 | — | — | 125,000 | Feb 22, 2024 | Feb 23, 2024 ↗ | View → |
| CGEM CULLINAN THERAPEUTICS, INC. | SALE Chief Medical Officer | 1,860 | $8.50 | $15.8K | 56,191 | Dec 21, 2023 | Dec 22, 2023 ↗ | View → |
| CGEM CULLINAN THERAPEUTICS, INC. | SALE Chief Medical Officer | 386 | $8.22 | $3.2K | 58,051 | Dec 18, 2023 | Dec 20, 2023 ↗ | View → |
| CGEM CULLINAN THERAPEUTICS, INC. | SALE Chief Medical Officer | 387 | $12.94 | $5.0K | 58,437 | Jun 20, 2023 | Jun 21, 2023 ↗ | View → |
| CGEM CULLINAN THERAPEUTICS, INC. | SALE Chief Medical Officer | 394 | $8.76 | $3.5K | 58,824 | May 18, 2023 | May 19, 2023 ↗ | View → |
| CGEM CULLINAN THERAPEUTICS, INC. | SALE Chief Medical Officer | 392 | $10.71 | $4.2K | 59,218 | Apr 18, 2023 | Apr 20, 2023 ↗ | View → |
| CGEM CULLINAN THERAPEUTICS, INC. | SALE Chief Medical Officer | 390 | $11.32 | $4.4K | 59,610 | Mar 20, 2023 | Mar 27, 2023 ↗ | View → |
| CGEM CULLINAN THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 60,000 | — | — | 60,000 | Feb 17, 2023 | Feb 21, 2023 ↗ | View → |
| CGEM CULLINAN THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 120,000 | — | — | 120,000 | Feb 17, 2023 | Feb 21, 2023 ↗ | View → |
| CGEM CULLINAN THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 215,000 | — | — | 215,000 | Feb 28, 2022 | Mar 2, 2022 ↗ | View → |